MB

MPM BioImpact Portfolio holdings

AUM $577M
This Quarter Return
-7.84%
1 Year Return
+8.33%
3 Year Return
+241.63%
5 Year Return
+127.38%
10 Year Return
–
AUM
$375M
AUM Growth
+$375M
Cap. Flow
-$73.1M
Cap. Flow %
-19.51%
Top 10 Hldgs %
61.48%
Holding
38
New
4
Increased
8
Reduced
6
Closed
6

Top Buys

1
OLMA icon
Olema Pharmaceuticals
OLMA
$17.2M
2
GPCR icon
Structure Therapeutics
GPCR
$11.6M
3
CBAY
Cymabay Therapeutics
CBAY
$9.11M
4
MORF
Morphic Holding, Inc. Common Stock
MORF
$4.58M
5
VKTX icon
Viking Therapeutics
VKTX
$3.6M

Top Sells

1
ISEE
IVERIC bio, Inc. Common Stock
ISEE
$47.8M
2
KDNY
Chinook Therapeutics, Inc. Common Stock
KDNY
$38.6M
3
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$23.9M
4
EWTX icon
Edgewise Therapeutics
EWTX
$5.52M
5
KALV icon
KalVista Pharmaceuticals
KALV
$1.77M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
MORF
26
DELISTED
Morphic Holding, Inc. Common Stock
MORF
$4.58M 1.22%
+200,000
New +$4.58M
ADAP
27
Adaptimmune Therapeutics
ADAP
$13.9M
$3.97M 1.06%
5,095,912
– –
VRDN icon
28
Viridian Therapeutics
VRDN
$1.59B
$3.92M 1.05%
255,323
– –
PHAT icon
29
Phathom Pharmaceuticals
PHAT
$843M
$3.6M 0.96%
347,332
+65,000
+23% +$674K
VKTX icon
30
Viking Therapeutics
VKTX
$3.02B
$3.6M 0.96%
+325,000
New +$3.6M
INZY
31
DELISTED
Inozyme Pharma
INZY
$1.37M 0.37%
326,921
– –
HARP
32
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
$1.29M 0.34%
319,670
-2,877,037
-90% -$4
EWTX icon
33
Edgewise Therapeutics
EWTX
$1.54B
– –
-712,798
Closed -$5.52M
VTYX icon
34
Ventyx Biosciences
VTYX
$184M
– –
-31,747
Closed -$1.04M
RETA
35
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
– –
-234,478
Closed -$23.9M
KDNY
36
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
– –
-1,003,406
Closed -$38.6M
ISEE
37
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
– –
-1,214,662
Closed -$47.8M
ONCR
38
DELISTED
Oncorus, Inc.
ONCR
– –
-2,377,031
Closed -$96.3K
1
2